Literature DB >> 25298255

[Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers].

F Jockenhöfer1, H Gollnick, K Herberger, G Isbary, R Renner, M Stücker, E Valesky, U Wollina, M Weichenthal, S Karrer, B Ross, E Heintschel von Heinegg, J Dissemond.   

Abstract

BACKGROUND: Due to the increasing problem of antibiotic resistance in gram-negative pathogens, the Commission for Hospital Hygiene and Infection Prevention (KRINKO) decided to establish a new clinically oriented definition of multi-resistance. Gram-negative pathogens with a multidrug-resistance (MRGN) are divided into those with resistance to three (3MRGN) or four (4MRGN) antibiotic groups. PATIENTS AND METHODS: In this multicenter study which was done in ten dermatological wound clinics, the bacteriological swabs from up to 100 patients with chronic leg ulcers per center were analyzed according to the current classification KRINKO and evaluated.
RESULTS: Overall, the results of 970 patients (553 women, 417 men) could be evaluated. We found 681 gram-positive and 1155 gram-negative bacteria. Pseudomonas aeruginosa was with a detection-rate of 31.1% the most frequent gram-negative pathogen, followed by Proteus mirabilis with 13.7% and various enterobacteria with 28.6%. According to the current KRINKO classification,eight patients with 4MRGN and 34 patients with 3MRGN could be identified.
CONCLUSIONS: Our results demonstrate the current spectrum of bacteria in patients with chronic leg ulcers with a variety of gram-negative pathogens, some of which are classified as multi-drug resistant. As a clinical consequence some of the patients require individualized preventive measures and therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25298255     DOI: 10.1007/s00105-014-3523-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  30 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

Authors:  Ronald N Jones
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

Review 3.  Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO).

Authors:  M F Q Kluytmans-Vandenbergh; J A J W Kluytmans; A Voss
Journal:  Infection       Date:  2005-10       Impact factor: 3.553

Review 4.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.

Authors:  Aurora E Pop-Vicas; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

7.  National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Pseudomonas aeruginosa displays an epidemic population structure.

Authors:  Jean-Paul Pirnay; Daniel De Vos; Christel Cochez; Florence Bilocq; Alain Vanderkelen; Martin Zizi; Bart Ghysels; Pierre Cornelis
Journal:  Environ Microbiol       Date:  2002-12       Impact factor: 5.491

9.  Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

Authors:  Douglas J Biedenbach; Gary J Moet; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

10.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

View more
  1 in total

1.  Selenazolinium Salts as "Small Molecule Catalysts" with High Potency against ESKAPE Bacterial Pathogens.

Authors:  Karolina Witek; Muhammad Jawad Nasim; Markus Bischoff; Rosmarie Gaupp; Pavel Arsenyan; Jelena Vasiljeva; Małgorzata Anna Marć; Agnieszka Olejarz; Gniewomir Latacz; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik; Claus Jacob
Journal:  Molecules       Date:  2017-12-08       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.